PACS Group (NYSE:PACS) and Cannlabs (OTCMKTS:CANL) Head to Head Analysis

Cannlabs (OTCMKTS:CANLGet Free Report) and PACS Group (NYSE:PACSGet Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, valuation, earnings and dividends.

Risk & Volatility

Cannlabs has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, PACS Group has a beta of -0.68, suggesting that its stock price is 168% less volatile than the S&P 500.

Earnings and Valuation

This table compares Cannlabs and PACS Group”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Cannlabs N/A N/A N/A N/A N/A
PACS Group $4.09 billion 1.51 $55.76 million $1.05 37.67

PACS Group has higher revenue and earnings than Cannlabs.

Analyst Recommendations

This is a summary of current ratings and price targets for Cannlabs and PACS Group, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cannlabs 0 0 0 0 0.00
PACS Group 1 1 5 0 2.57

PACS Group has a consensus price target of $39.40, indicating a potential downside of 0.39%. Given Cannlabs’ higher possible upside, analysts clearly believe Cannlabs is more favorable than PACS Group.

Profitability

This table compares Cannlabs and PACS Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Cannlabs N/A N/A N/A
PACS Group 3.29% 21.39% 3.09%

Summary

PACS Group beats Cannlabs on 6 of the 8 factors compared between the two stocks.

About Cannlabs

(Get Free Report)

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.

About PACS Group

(Get Free Report)

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Receive News & Ratings for Cannlabs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannlabs and related companies with MarketBeat.com's FREE daily email newsletter.